Uncategorized
NovaBay Pharmaceuticals Conference Call Today, June 9th, 2015, at 12:00 p.m. Eastern Time
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing novel approaches for the global eye care market including revolutionary non-antibiotic antimicrobial products, will host an investment community conference call today, June 9th, 2015. Management will discuss the attributes of its FDA-cleared intelli-Case for safely disinfecting contact lenses with hydrogen peroxide announced in its press release issued
